"LFB was founded in 1994 in France and is among the leading European bio-pharmaceutical companies providing healthcare professionals, with blood-derived therapeutics with the vision to provide treatment options to patients in three major areas: immunology, haemostasis, and intensive care. LFB currently markets 15 products in more than 30 countries. Please visit www.groupe-lfb.com for additional information."
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze